These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 15043715)

  • 1. S100A5: a marker of recurrence in WHO grade I meningiomas.
    Hancq S; Salmon I; Brotchi J; De Witte O; Gabius HJ; Heizmann CW; Kiss R; Decaestecker C
    Neuropathol Appl Neurobiol; 2004 Apr; 30(2):178-87. PubMed ID: 15043715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of S100B, S100A6 and galectin-3 ligands in meningiomas as markers of aggressiveness.
    Hancq S; Salmon I; Brotchi J; Gabius HJ; Heizmann CW; Kiss R; Decaestecker C
    Int J Oncol; 2004 Nov; 25(5):1233-40. PubMed ID: 15492810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Ki-67 proliferation antigen in meningiomas. Experience in 600 cases.
    Roser F; Samii M; Ostertag H; Bellinzona M
    Acta Neurochir (Wien); 2004 Jan; 146(1):37-44; discussion 44. PubMed ID: 14740263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistochemical expression of SPARC is correlated with recurrence, survival and malignant potential in meningiomas.
    Bozkurt SU; Ayan E; Bolukbasi F; Elmaci I; Pamir N; Sav A
    APMIS; 2009 Sep; 117(9):651-9. PubMed ID: 19703125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does protein expression predict recurrence of benign World Health Organization grade I meningioma?
    Kärjä V; Sandell PJ; Kauppinen T; Alafuzoff I
    Hum Pathol; 2010 Feb; 41(2):199-207. PubMed ID: 19801161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of Ki-67/MIB-1 proliferation index in meningiomas.
    Torp SH; Lindboe CF; Grønberg BH; Lydersen S; Sundstrøm S
    Clin Neuropathol; 2005; 24(4):170-4. PubMed ID: 16033133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary resected meningiomas: relapses and proliferation markers.
    Kalala JP; Caemaert J; De Ridder L
    In Vivo; 2004; 18(4):411-6. PubMed ID: 15369177
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of alkaline phosphatase activity predicts meningioma recurrence.
    Bouvier C; Liprandi A; Colin C; Giorgi R; Quilichini B; Metellus P; Figarella-Branger D
    Am J Clin Pathol; 2005 Aug; 124(2):252-8. PubMed ID: 16040297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation between histological grade, MIB-1, p53, and recurrence in 69 completely resected primary intracranial meningiomas with a 6 year mean follow-up.
    Lanzafame S; Torrisi A; Barbagallo G; Emmanuele C; Alberio N; Albanese V
    Pathol Res Pract; 2000; 196(7):483-8. PubMed ID: 10926326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recurrence and regrowth of benign meningiomas.
    Nakasu S; Fukami T; Jito J; Nozaki K
    Brain Tumor Pathol; 2009; 26(2):69-72. PubMed ID: 19856217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Proliferative markers of meningiomas: immunohistochemical analysis and prognostic value].
    Korshunov AG; Shishkina LV; Golanov AV
    Arkh Patol; 2002; 64(1):29-33. PubMed ID: 11889696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of apoptotic and proliferation markers in meningiomas.
    Konstantinidou AE; Pavlopoulos PM; Patsouris E; Kaklamanis L; Davaris P
    J Pathol; 1998 Nov; 186(3):325-30. PubMed ID: 10211124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between laminin γ1 expression and meningioma grade, recurrence, and progression-free survival.
    Ke HL; Ke RH; Li B; Wang XH; Wang YN; Wang XQ
    Acta Neurochir (Wien); 2013 Jan; 155(1):165-71. PubMed ID: 23053286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation between histological grade and MIB-1 and p53 immunoreactivity in meningiomas.
    Ozen O; Demirhan B; Altinörs N
    Clin Neuropathol; 2005; 24(5):219-24. PubMed ID: 16167545
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased expression of avian erythroblastosis virus E26 oncogene homolog 1 in World Health Organization grade 1 meningiomas is associated with an elevated risk of recurrence and is correlated with the expression of its target genes matrix metalloproteinase-2 and MMP-9.
    Okuducu AF; Zils U; Michaelis SA; Mawrin C; von Deimling A
    Cancer; 2006 Sep; 107(6):1365-72. PubMed ID: 16894529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiogenesis in intracranial meningiomas: immunohistochemical and molecular study.
    Pistolesi S; Boldrini L; Gisfredi S; De Ieso K; Camacci T; Caniglia M; Lupi G; Leocata P; Basolo F; Pingitore R; Parenti G; Fontanini G
    Neuropathol Appl Neurobiol; 2004 Apr; 30(2):118-25. PubMed ID: 15043709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Report of seven cases of clear-cell meningioma and a literature review].
    Rousselot C; Francois P; Jan M; Bergemer AM
    Ann Pathol; 2010 Apr; 30(2):73-82. PubMed ID: 20451062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Can recurrence of meningiomas be predicted?
    Kalala JP; Benoit D; De Ridder L
    Anticancer Res; 2004; 24(4):2319-24. PubMed ID: 15330178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proliferation and progesterone receptor status in benign meningiomas are not age dependent.
    Roser F; Nakamura M; Ritz R; Bellinzona M; Dietz K; Samii M; Tatagiba MS
    Cancer; 2005 Aug; 104(3):598-601. PubMed ID: 15952201
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinicopathologic features of aggressive meningioma emphasizing the role of radiotherapy in treatment.
    Engenhart-Cabillic R; Farhoud A; Sure U; Heinze S; Henzel M; Mennel HD; Bertalanffy H
    Strahlenther Onkol; 2006 Nov; 182(11):641-6. PubMed ID: 17072521
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.